Reininger Cornelia 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Nov 2, 2012
Insider Transaction Report
Form 4
Reininger Cornelia
SVP & Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-11-01+88,000→ 88,000 totalExercise: $2.85Exp: 2022-11-01→ Common Stock (88,000 underlying)
Footnotes (1)
- [F1]Option vests 25% per year beginning on the first anniversary of the date of grant.